Implementation of a Routine Screening Program for Latent Tuberculosis Infection among Patients with Acute Leukemia at a Canadian Cancer Center.
Rabab TahaSagar KothariFarid ForoutanMelissa Randy GitmanVikas K GuptaTram NguyenColeman RotsteinPublished in: Current oncology (Toronto, Ont.) (2022)
Universal screening with TST may be of low yield in individuals with acute leukemia unless patients originate from a TB endemic country. When therapy for LTBI is prescribed, patients with acute leukemia do not experience drug-induced liver toxicity and are likely to complete the intended duration of therapy, thus preventing the development of active tuberculosis.
Keyphrases
- drug induced
- mycobacterium tuberculosis
- liver injury
- end stage renal disease
- ejection fraction
- quality improvement
- chronic kidney disease
- adverse drug
- healthcare
- pulmonary tuberculosis
- hiv aids
- peritoneal dialysis
- papillary thyroid
- prognostic factors
- patient reported outcomes
- mesenchymal stem cells
- young adults
- childhood cancer
- hiv infected
- lymph node metastasis
- electronic health record